Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency

NCT00004801 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Hemophilia B
Factor IX Deficiency

Interventions

DRUG: monoclonal factor IX replacement therapy

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]